BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 28303517)

  • 1. Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
    Wu L; Mo W; Zhang Y; Zhou M; Li Y; Zhou R; Xu S; Pan S; Deng H; Mao P; Wang S
    Int J Hematol; 2017 Jul; 106(1):71-81. PubMed ID: 28303517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Hu Y; Zhang XH; Wang YZ; Mo XD; Zhang YY; Wang Y; Han W; Xu LP; Chang YJ; Huang XJ
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1190-7. PubMed ID: 24792870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of hematopoietic stem cell niches in patients with aplastic anemia.
    Wu L; Mo W; Zhang Y; Deng H; Li Y; Zhou R; Zhang L; Pan S; Wang S
    Int J Hematol; 2015 Dec; 102(6):645-53. PubMed ID: 26440975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Chang YJ; Wang YZ; Chen YH; Han W; Wang Y; Sun YQ; Yan CH; Wang FR; Liu YR; Xu LP; Liu DH; Huang XJ
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1465-73. PubMed ID: 23879970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
    Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
    Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enumeration of bone marrow plasmacytoid dendritic cells by multiparameter flow cytometry as a prognostic marker following allogeneic hematopoietic stem cell transplantation.
    Su RJ; Green R; Chen M
    Blood Cells Mol Dis; 2018 Mar; 69():107-112. PubMed ID: 29137845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Song Y; Shi MM; Zhang YY; Mo XD; Wang Y; Zhang XH; Xu LP; Huang XJ; Kong Y
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):906-912. PubMed ID: 28286199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia.
    Lu S; Ge M; Zheng Y; Li J; Feng X; Feng S; Huang J; Feng Y; Yang D; Shi J; Chen F; Han Z
    Stem Cell Res Ther; 2017 Aug; 8(1):178. PubMed ID: 28764810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplant.
    Ding L; Zhu H; Yang Y; Wang ZD; Zheng XL; Yan HM; Dong L; Zhang HH; Han DM; Xue M; Liu J; Zhu L; Guo ZK; Wang HX
    Leuk Lymphoma; 2014 Jul; 55(7):1635-44. PubMed ID: 24180332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.
    Kong Y; Wang YT; Cao XN; Song Y; Chen YH; Sun YQ; Wang Y; Zhang XH; Xu LP; Huang XJ
    J Transl Med; 2017 Mar; 15(1):57. PubMed ID: 28292332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
    Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
    Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
    Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
    Wang Z-; Yu H-; Cao F-; Liu Z-; Liu Z-; Feng W-; Liu X-; Yu Y-; Xiao Y; Li L-; Zhou J
    Ann Hematol; 2019 Feb; 98(2):473-479. PubMed ID: 30341538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections.
    Yue C; Ding Y; Gao Y; Li L; Pang Y; Liu Z; Zhang H; Xiao Y; Jiang Z; Xiao H
    Eur J Haematol; 2018 Jun; 100(6):624-629. PubMed ID: 29532539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
    Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
    Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation.
    Zhao HY; Lyu ZS; Duan CW; Song Y; Han TT; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    Br J Haematol; 2018 Sep; 182(5):679-692. PubMed ID: 29974948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specially modified stromal and immune microenvironment in injected bone marrow following intrabone transplantation facilitates allogeneic hematopoietic stem cell engraftment.
    Chen C; Su Y; Chen J; Song Y; Zhuang R; Xiao B; Guo S
    Exp Hematol; 2016 Jul; 44(7):614-623.e3. PubMed ID: 27090963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia.
    Aladag E; Goker H; Demiroglu H; Aksu S; Sayinalp N; Haznedaroglu IC; Ozcebe OI; Buyukasik Y
    Transfus Apher Sci; 2021 Apr; 60(2):103050. PubMed ID: 33446450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.